Technical analysis of PureTech Health plc (PRTC): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others.
Price Performance
| 1 month | +0.00% |
| 3 months | +0.00% |
| Year-to-date | +4.69% |
| 1 year | +17.78% |
| 3 years | -39.93% |
| 5 years | -64.67% |
52-Week Range
| 52-week High | $19.92 |
| 52-week Low | $14.50 |
| Avg Volume (90d) | 7K |
Technical Indicators
| SMA 50 | $16.83 |
| SMA 200 | $17.25 |
| Beta | 0.71 |
| 30-day Volatility (annualised) | 47.6% |
| Price vs SMA 50 | +3.5% |
| Price vs SMA 200 | +1.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $17.77 | |
| 2025-11 | $16.70 | -6.0% |
| 2025-12 | $16.64 | -0.4% |
| 2026-01 | $18.69 | +12.3% |
| 2026-02 | $16.77 | -10.3% |
| 2026-03 | $14.86 | -11.4% |
| 2026-04 | $17.25 | +16.1% |
| 2026-05 | $17.42 | +1.0% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | $-0.05 | $8M |
| 2026-09-14 | $0.06 | $3M |
| 2026-09-14 | | |
| 2026-09-14 | $0.12 | $7M |
| 2026-09-14 | | |
Price
| Price | $17.38 |
| Market Cap | $4.2B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.13 |
| EV / EBITDA | -42.07 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.06 |
| Current Ratio | 6.59 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 0.25 |